Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-232 Overview: For patients with community-acquired pneumonia (CAP), wide variation in the duration of treatment exists. Longer duration of treatment may increase the risk of adverse effects and lead to antibiotic resistance. However, shorter duration of treatment may result in treatment failure. See what new evidence shows may be the best antibiotics treatment duration in most patients with CAP. Episode resource links: Dinh A et al. Pneumonia Short Treatment (PTC) Study Group. Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet. 2021 Mar 27;397(10280):1195-1203 Metlay JP et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67. Guest: Alan Ehrlich MD, FAAFP Music Credit: Richard Onorato

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.